RKI-1313 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a potent inhibitor targeting specific enzymes or receptors involved in disease pathways. Researchers employ RKI-1313 in preclinical studies to evaluate its efficacy in modulating biological processes, particularly in cancer therapy or inflammatory diseases. Its application extends to high-throughput screening assays to identify potential therapeutic candidates. Additionally, RKI-1313 is used in mechanistic studies to understand molecular interactions and signaling pathways, aiding in the design of more effective and selective drugs. Its role in advancing targeted therapies makes it a valuable tool in modern pharmaceutical research.